• GenoMed to Offer Nationwide Influenza Trial
    ST. LOUIS -- GenoMed, Inc. a Next Generation DM(TM) (Disease Management) company that uses its expertise in genomics to improve clinical outcomes, announced today that it will offer its patent-pending broad spectrum viral antidote to the nation during this coming flu season ...More
    October 7, 2004 Posted in News
  • Gene from 1918 Virus Proves Key to Virulent Influenza
    Using a gene resurrected from the virus that caused the 1918 Spanish influenza pandemic, recorded history's most lethal outbreak of infectious disease, scientists have found that a single gene may have been responsible for the devastating virulence of the virus. In the ...More
    October 7, 2004 Posted in News
  • With Limited Flu Vaccine, Leading Infection Control Group Offers Preventive Tips
    WASHINGTON, D.C. -- Concerned about the recent announcement that a major influenza vaccine manufacturer has suspended vaccine production for the 2004-2005 flu season, the Association for Professionals in Infection Control and Epidemiology (APIC), a preeminent organization ...More
    October 6, 2004 Posted in News
  • Interim Influenza Vaccination Recommendations: 2004-05
    On October 5, 2004, CDC was notified by Chiron Corporation that none of its influenza vaccine (Fluvirin®) would be available for distribution in the United States for the 2004-05 influenza season. The company indicated that the Medicines and Healthcare products Regulatory ...More
    October 6, 2004 Posted in News
  • HHS Issues Statement Regarding Chiron Flu Vaccine
    The following is a statement from the Department of Health and Human Services: “Clearly, the loss of the Chiron flu vaccine poses a serious challenge to our vaccine supply for the upcoming flu season. Chiron was to produce between 46 to 48 million doses of influenza vaccine ...More
    October 5, 2004 Posted in News
  • Flu Vaccine Needed to Protect Children Under Age Two
    WASHINGTON -- The American Academy of Pediatrics (AAP) reiterated the need for children ages six months to 23 months to get vaccinated with the flu vaccine in a written statement submitted for a U.S. House of Representatives hearing. “The flu kills,” said AAP president ...More
    October 5, 2004 Posted in News
  • Carrington Subsidiary Receives $6 Million Biodefense Grant to Develop Nasal Flu Vaccine
    IRVING, Texas -- Carrington Laboratories, Inc. announced that its wholly-owned subsidiary, DelSite Biotechnologies, Inc., has been awarded a $6 million grant from the National Institute of Allergy and Infectious Diseases to develop an inactivated influenza nasal powder ...More
    October 5, 2004 Posted in News, PPE & Standard Precautions
  • Spring-fall Flu Shots Safe, Protect Children
    DURHAM, N.C. – Giving flu vaccine to toddlers in the spring and fall guards against infection and is easier on parents than the fall schedule of two doses administered a month apart, found researchers from Duke University Medical Center and the University of Washington. The ...More
    October 5, 2004 Posted in News
  • Chiron Unable to Supply Fluvirin Influenza Virus Vaccine for 2004-2005 Season
    EMERYVILLE, Calif. -- Chiron Corporation announced that the UK regulatory body, the Medicines and Healthcare Products Regulatory Agency (MHRA), has today temporarily suspended the company’s license to manufacture Fluvirin® influenza virus vaccine in its Liverpool facility, ...More
    October 5, 2004 Posted in News
  • Ohio Department of Health Ships Flu Vaccine to Local Health Departments
    COLUMBUS --  The Ohio Department of Health (ODH) last week began shipping 270,000 doses of influenza vaccine to Ohio’s local health departments. This ODH-supplied vaccine is to be given only to high-risk people, including adults 65 and older, children 6 to 23 months ...More
    October 4, 2004 Posted in News